Priyam Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 26 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth -110.00%
- Ebitda -110.00%
- Net Worth -32.85%
- Total Assets %
About Priyam Pharmachem
Priyam Pharmachem Private Limited (PPPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 January 2014 and has a history of 11 years. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Priya Iyer, Preetha Iyer, and Mahadevan Iyer serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100MH2014PTC251785
-
Company No.
251785
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
06 Jan 2014
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Priyam Pharmachem?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Preetha Iyer
|
Director | 06-Jan-2014 | Current |
|
Priya Iyer
|
Director | 06-Jan-2014 | Current |
|
Mahadevan Iyer
|
Director | 06-Jan-2014 | Current |
Financial Performance of Priyam Pharmachem.
Priyam Pharmachem Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 110% decrease in profit. The company's net worth observed a substantial decline by a decrease of 32.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Priyam Pharmachem?
In 2017, Priyam Pharmachem had a promoter holding of 99.00% and a public holding of 1.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Preetham Pharmachem Private LimitedPriya Iyer, Preetha Iyer and 1 more are mutual person
-
Devika Developer Llp
Mahadevan Iyer is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Priyam Pharmachem?
Unlock and access historical data on people associated with Priyam Pharmachem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Priyam Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Priyam Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
